Longitudinal bioluminescence imaging of the dynamics of doxorubicin induced apoptosis

Theranostics

Volumn 3, Issue 3, 2013, Pages 190-200

  Niu, Gang ^a   Zhu, Lei ^a,b   Ho, Don N ^a   Zhang, Fan ^a,b   Gao, Haokao ^a   Quan, Qimeng ^a   Hida, Naoki ^a   Ozawa, Takeaki ^c   Liu, Gang ^b   Chen, Xiaoyuan ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^b XIAMEN UNIVERSITY   (China)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; Bioluminescence imaging; Caspase 3; Cyclic firefly luciferase; Doxorubicin

Indexed keywords

CASPASE 3; DOXORUBICIN; FIREFLY LUCIFERASE; LIPOCORTIN 5; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; BIOLUMINESCENCE IMAGING; BREAST CANCER; CANCER CELL CULTURE; CELL ENGINEERING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG MONITORING; ENZYME ACTIVATION; EX VIVO STUDY; FEMALE; FLUORESCENCE IMAGING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IC 50; IMAGING; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; CASPASE-3.; CYCLIC FIREFLY LUCIFERASE; DIAGNOSTIC IMAGING; DISEASE MODEL; GENETICS; LUMINESCENCE; METABOLISM; METHODOLOGY; NEOPLASM; NICK END LABELING; REPORTER GENE; TIME; TUMOR CELL LINE;

APOPTOSIS; BIOLUMINESCENCE IMAGING; CASPASE-3.; CYCLIC FIREFLY LUCIFERASE; DOXORUBICIN;

ANIMALS; ANNEXIN A5; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; DOXORUBICIN; GENES, REPORTER; HUMANS; IN SITU NICK-END LABELING; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MICE; NEOPLASMS; TIME FACTORS;

EID: 84882947458     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.5825     Document Type: Article

References (48)

1. Hengartner MO. The biochemistry of apoptosis. Nature. 2000; 407: 770-6. doi:10.1038/35037710.
2. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35: 495-516. doi:779478428 [pii]10.1080/01926230701320337.
3. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002; 2: 277-88. doi:10.1038/nrc776.
4. Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer. 2005; 5: 876-85. doi:nrc1736 [pii]10.1038/nrc1736.
5. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002; 108: 153-64. doi:S0092867402006256 [pii].
6. Kaufmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res. 2000; 256: 42-9. doi:10.1006/excr.2000.4838S0014-4827(00)94838-9 [pii].
7. Laxman B, Hall DE, Bhojani MS, Hamstra DA, Chenevert TL, Ross BD, et al. Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A. 2002; 99: 16551-5. doi:10.1073/pnas.252644499252644499 [pii].
8. Coppola JM, Ross BD, Rehemtulla A. Noninvasive imaging of apoptosis and its application in cancer therapeutics. Clin Cancer Res. 2008; 14: 2492-501. doi:14/8/2492 [pii]10.1158/1078-0432.CCR-07-0782.
9. Niu G, Chen X. Has molecular and cellular imaging enhanced drug discovery and drug development? Drugs R D. 2008; 9: 351-68. doi:962 [pii].
10. Antczak C, Takagi T, Ramirez CN, Radu C, Djaballah H. Live-cell imaging of caspase activation for high-content screening. J Biomol Screen. 2009; 14: 956-69. doi:1087057109343207 [pii]10.1177/1087057109343207.
11. Ozaki M, Haga S, Ozawa T. In vivo monitoring of liver damage using caspase-3 probe. Theranostics. 2012; 2: 207-14. doi:10.7150/thno.3806.
12. Liu G, Swierczewska M, Lee S, Chen X. Functional nanoparticles for molecular imaging guided gene delivery. Nano Today. 2010; 5: 524-39.
13. Liu G, Swierczewska M, Niu G, Zhang X, Chen X. Molecular imaging of cell-based cancer immunotherapy. Mol Biosyst. 2011;7:993-1003. doi:10.1039/c0mb00198h.
14. Liu G, Yang H, Zhang XM, Shao Y, Jiang H. MR imaging for the longevity of mesenchymal stem cells labeled with poly-L-lysine-Resovist complexes. Contrast Media Mol Imaging. 2010;5: 53-8. doi:10.1002/cmmi.362.
15. Niu G, Gaut AW, Ponto LL, Hichwa RD, Madsen MT, Graham MM, et al. Multimodality noninvasive imaging of gene transfer using the human sodium iodide symporter. J Nucl Med. 2004; 45: 445-9.
16. Zhang L, Lee KC, Bhojani MS, Khan AP, Shilman A, Holland EC, et al. Molecular imaging of Akt kinase activity. Nat Med. 2007; 13: 1114-9. doi:nm1608 [pii]10.1038/nm1608.
17. Hickson J, Ackler S, Klaubert D, Bouska J, Ellis P, Foster K, et al. Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin. Cell Death Differ. 2010; 17: 1003-10. doi:cdd2009205 [pii]10.1038/cdd.2009.205.
18. Zhang F, Zhu L, Liu G, Hida N, Lu G, Eden HS, et al. Multimodality imaging of tumor response to doxil. Theranostics. 2011; 1: 302-9.
19. Schellenberger E, Schnorr J, Reutelingsperger C, Ungethum L, Meyer W, Taupitz M, et al. Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis. Small. 2008; 4: 225-30. doi:10.1002/smll.200700847.
20. Lee KC, Hamstra DA, Bhojani MS, Khan AP, Ross BD, Rehemtulla A. Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy. Clin Cancer Res. 2007; 13: 1839-46. doi:13/6/1839 [pii]10.1158/1078-0432.CCR-06-1657.
21. Medarova Z, Rashkovetsky L, Pantazopoulos P, Moore A. Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging. Cancer Res. 2009; 69: 1182-9. doi:0008-5472.CAN-08-2001 [pii]10.1158/0008-5472.CAN-08-2001.
22. Blankenberg FG. Imaging the molecular signatures of apoptosis and injury with radiolabeled annexin V. Proc Am Thorac Soc. 2009; 6: 469-76. doi:6/5/469 [pii]10.1513/pats.200901-001AW.
23. Michalski MH, Chen X. Molecular imaging in cancer treatment. Eur J Nucl Med Mol Imaging. 2009;38: 358-77. doi:10.1007/s00259-010-1569-z.
24. Niu G, Chen X. Apoptosis imaging: beyond annexin V. J Nucl Med. 2010; 51: 1659-62. doi:jnumed.110.078584 [pii]10.2967/jnumed.110.078584.
25. Ungethum L, Kenis H, Nicolaes GA, Autin L, Stoilova-McPhie S, Reutelingsperger CP. Engineered annexin a5 variants have impaired cell entry for molecular imaging of apoptosis using pretargeting strategies. J Biol Chem. 2011; 286: 1903-10. doi:M110.163527 [pii]10.1074/jbc.M110.163527.
26. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 1999; 6: 1028-42. doi:10.1038/sj.cdd.4400598.
27. Chen HH, Yuan H, Josephson L, Sosnovik DE. Theranostic Imaging of the Kinases and Proteases that Modulate Cell Death and Survival. Theranostics. 2012; 2: 148-55. doi:10.7150/thno.4077.
28. Savitsky AP, Rusanov AL, Zherdeva VV, Gorodnicheva TV, Khrenova MG, Nemukhin AV. FLIM-FRET Imaging of Caspase-3 Activity in Live Cells Using Pair of Red Fluorescent Proteins. Theranostics. 2012; 2: 215-26. doi:10.7150/thno.3885.
29. Kim K, Lee M, Park H, Kim JH, Kim S, Chung H, et al. Cell-permeable and biocompatible polymeric nanoparticles for apoptosis imaging. J Am Chem Soc. 2006; 128: 3490-1.
30. Quinti L, Weissleder R, Tung CH. A fluorescent nanosensor for apoptotic cells. Nano Lett. 2006; 6: 488-90.
31. Barnett EM, Zhang X, Maxwell D, Chang Q, Piwnica-Worms D. Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci U S A. 2009; 106: 9391-6.
32. Edgington LE, Berger AB, Blum G, Albrow VE, Paulick MG, Lineberry N, et al. Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat Med. 2009; 15: 967-73.
33. Ray P, De A, Patel M, Gambhir SS. Monitoring caspase-3 activation with a multimodality imaging sensor in living subjects. Clin Cancer Res. 2008; 14: 5801-9. doi:14/18/5801 [pii]10.1158/1078-0432.CCR-07-5244.
34. Kanno A, Yamanaka Y, Hirano H, Umezawa Y, Ozawa T. Cyclic luciferase for real-time sensing of caspase-3 activities in living mammals. Angew Chem Int Ed Engl. 2007; 46: 7595-9. doi:10.1002/anie.200700538.
35. Kanno A, Umezawa Y, Ozawa T. Detection of apoptosis using cyclic luciferase in living mammals. Methods Mol Biol. 2009; 574: 105-14. doi:10.1007/978-1-60327-321-3_9.
36. Liu G, Wang Z, Lu J, Xia C, Gao F, Gong Q, et al. Low molecular weight alkyl-polycation wrapped magnetite nanoparticle clusters as MRI probes for stem cell labeling and in vivo imaging. Biomaterials. 2011; 32: 528-37. doi:S0142-9612(10)01137-3 [pii]10.1016/j.biomaterials.2010.08.099.
37. Peterson QP, Goode DR, West DC, Botham RC, Hergenrother PJ. Preparation of the caspase-3/7 substrate Ac-DEVD-pNA by solution-phase peptide synthesis. Nat Protoc. 2010;5: 294-302.
38. O'Brien MA, Daily WJ, Hesselberth PE, Moravec RA, Scurria MA, Klaubert DH, et al. Homogeneous, bioluminescent protease assays: caspase-3 as a model. J Biomol Screen. 2005; 10: 137-48. doi:10/2/137 [pii]10.1177/1087057104271865.
39. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001; 411: 342-8.
40. Young RC, Ozols RF, Myers CE. The anthracycline antineoplastic drugs. N Engl J Med. 1981; 305: 139-53. doi:10.1056/NEJM198107163050305.
41. Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science. 1984; 226: 466-8.
42. Keizer HG, Pinedo HM, Schuurhuis GJ, Joenje H. Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther. 1990; 47: 219-31. doi:0163-7258(90)90088-J [pii].
43. Meyn RE, Stephens LC, Hunter NR, Milas L. Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int J Cancer. 1995; 60: 725-9.
44. Meijer AE, Jernberg AR, Heiden T, Stenerlow B, Persson LM, Tilly N, et al. Dose and time dependent apoptotic response in a human melanoma cell line exposed to accelerated boron ions at four different LET. Int J Radiat Biol. 2005; 81: 261-72. doi:V434316V52P16420 [pii]10.1080/09553000500141215.
45. Erba PA, Manfredi C, Lazzeri E, Minichilli F, Pauwels EK, Sbrana A, et al. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer. J Nucl Med. 2010; 51: 775-81. doi:jnumed.109.071621 [pii]10.2967/jnumed.109.071621.
46. Scabini M, Stellari F, Cappella P, Rizzitano S, Texido G, Pesenti E. In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation. Apoptosis. 2011;16:198-207. doi: 10.1007/s10495-010-0553-1.
47. Ke S, Wen X, Wu QP, Wallace S, Charnsangavej C, Stachowiak AM, et al. Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V. J Nucl Med. 2004; 45: 108-15.
48. Hu S, Kiesewetter DO, Zhu L, Guo N, Gao H, Liu G, et al. Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V. Mol Imaging Biol. 2012; 14: 762-70. doi:10.1007/s11307-012-0551-5